Celltrion begins Covid-19 human clinical trial with antiviral antibody treatment

Celltrion begins Covid-19 human clinical trial with antiviral antibody treatment

Source: 
Pharmaceutical Business Review
snippet: 


Celltrion Group has commenced phase 1 human clinical study to assess the potential of its antiviral antibody treatment for patients with Covid-19.